At the J.P. Morgan Healthcare Conference, Boston Scientific forecast that pulsed field ablation will be used in more than 60% of atrial fibrillation procedures globally by 2026.

Just months after FDA approval, Johnson & Johnson paused the rollout of its Varipulse pulsed field ablation (PFA) platform in ...

XSensetm system's innovative cryogenic connector technology designed to improve safety and maintain the integrity of cryogen used in the cryoablation procedure CAESAREA, Israel, Jan. 3 ...

Background: Cryoablation (CRYO) is an alternative to radiofrequency (RF) ablation in the treatment of atrioventricular nodal reentrant tachycardia (AVNRT). This study aims to evaluate the ...

Snezhnaya was widely believed to be released in Genshin Impact’s 6.0 update after the ongoing Natlan series updates concluded. However, a recent leak claims that Snezhnaya won’t be released ...

As in years past, treatment options for patients with atrial fibrillation garnered much of the spotlight in 2024 in terms of the major developments in the field of heart rhythm disorders. Though ...

Looking at the universe of stocks we cover at Dividend Channel, on 12/27/24, Medtronic PLC (Symbol: MDT), DENTSPLY SIRONA Inc (Symbol: XRAY), and Danaher Corp (Symbol: DHR) will all trade ex ...

Medtronic remains a "Buy" due to its undervalued stock, recent product launches, and resolved supply chain issues, despite underperformance over the past 7 months. The company posted solid Q2 ...

(UT Southwestern Medical Center) Cryoablation has not been approved by the U.S. Food and Drug Administration for breast cancer treatment, although an advisory committee for the agency did recently ...